Sept 8: At the end of July, Citius Pharmaceuticals received a Complete Response Letter from the FDA pertaining to its Biologics License Application for Lymphir, an engineered IL-2-diphtheria toxin fusion protein intended to treat relapsed or refractory cutaneous T-cell lymphoma
Whether single dosing or multiple dosing after reaching steady state, brensocatib blood exposure showed dose-dependent increases with similar systemic exposure levels between different races
The solubility mainly depends on the sequence of the peptide
A subcutaneous injection is a dose of a medication given into the layer of fat between the skin and the underlying muscle
Journal of Immunology Research , 2021 , 1-9
Please consult with your healthcare provider regarding specific dosing recommendations, below are general dosing guidelines* Injectable: Reconstitute with 6mLs of BAC water and inject 20 units (2mg) SQ daily, to achieve maximal benefits it is recommended to use this medication for 3-6 months
